A DOUBLE-BLIND, PLACEBO-CONTROLLED CROSSOVER TRIAL OF 3,4 DIAMINOPYRIDINE IN THE SYMPTOMATIC TREATMENT OF MULTIPLE-SCLEROSIS

被引：0
|
作者：
CARTER, JL
STEVENS, JC
SMITH, B
CASELLI, RJ
METCALF, A
WINDEBANK, A
ZINSMEISTER, A
RODRIGUEZ, M
机构：
来源：
ANNALS OF NEUROLOGY | 1993年 / 34卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：272 / 273
页数：2
相关论文
共 50 条
  • [21] Gabapentin for Parkinsonism: A double-blind, placebo-controlled, crossover trial
    Olson, WL
    Gruenthal, M
    Mueller, ME
    Olson, WH
    AMERICAN JOURNAL OF MEDICINE, 1997, 102 (01): : 60 - 66
  • [22] A Randomized, Double-Blind, Placebo-Controlled Trial of Duloxetine for the Treatment of Pain in Patients with Multiple Sclerosis
    Vollmer, Timothy L.
    Robinson, Michael J.
    Risser, Richard C.
    Malcolm, Sandra K.
    PAIN PRACTICE, 2014, 14 (08) : 732 - 744
  • [23] Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine
    Rossini, PM
    Pasqualetti, P
    Pozzilli, C
    Grasso, MG
    Millefiorini, E
    Graceffa, A
    Carlesimo, GA
    Zibellini, G
    Caltagirone, C
    MULTIPLE SCLEROSIS, 2001, 7 (06): : 354 - 358
  • [24] HYPERBARIC-OXYGEN IN MULTIPLE-SCLEROSIS - A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED STUDY
    CONFAVREUX, C
    MATHIEU, C
    CHACORNAC, R
    AIMARD, G
    DEVIC, M
    PRESSE MEDICALE, 1986, 15 (28): : 1319 - 1322
  • [25] ω-3 Fatty Acid Treatment in Multiple Sclerosis (OFAMS Study) A Randomized, Double-Blind, Placebo-Controlled Trial
    Torkildsen, Oivind
    Wergeland, Stig
    Bakke, Soren
    Beiske, Antonie G.
    Bjerve, Kristian S.
    Hovdal, Harald
    Midgard, Rune
    Lilleas, Finn
    Pedersen, Tom
    Bjornara, Bard
    Dalene, Froydis
    Kleveland, Grethe
    Schepel, Jan
    Olsen, Inge Christoffer
    Myhr, Kjell-Morten
    ARCHIVES OF NEUROLOGY, 2012, 69 (08) : 1044 - 1051
  • [26] Efficacy of 3,4-Diaminopyridine and Pyridostigmine in the Treatment of Lambert-Eaton Myasthenic Syndrome: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
    Wirtz, P. W.
    Verschuuren, J. J.
    van Dijk, J. G.
    de Kam, M. L.
    Schoemaker, R. C.
    van Hasselt, J. G. C.
    Titulaer, M. J.
    Tjaden, U. R.
    den Hartigh, J.
    van Gerven, J. M. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (01) : 44 - 48
  • [27] IVIG TREATMENT IN MULTIPLE-SCLEROSIS - PILOT-STUDY RESULTS AND DESIGN OF A PLACEBO-CONTROLLED, DOUBLE-BLIND CLINICAL-TRIAL
    NOSEWORTHY, JH
    RODRIGUEZ, M
    AN, KN
    HUNT, C
    JOHNSON, M
    STOLPSMITH, KA
    PETTERSON, TM
    OBRIEN, PC
    WEINSHENKER, BG
    SMITH, M
    ANNALS OF NEUROLOGY, 1994, 36 (02) : 325 - 325
  • [28] 4-AMINOPYRIDINE IMPROVES NEUROLOGICAL DEFICITS IN MULTIPLE-SCLEROSIS PATIENTS - DEMONSTRATION IN A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    BEVER, CT
    YOUNG, D
    ANDERSON, P
    KRUMHOLZ, A
    CONWAY, K
    LESLIE, J
    EDDINGTON, N
    PLAISANCE, K
    PANITCH, H
    JOHNSON, K
    ROSENBERG, L
    DEVANE, J
    NEUROLOGY, 1992, 42 (07) : 1427 - 1427
  • [29] HYPERBARIC-OXYGEN AND MULTIPLE-SCLEROSIS - SHORT-TERM RESULTS OF A PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
    BARNES, MP
    CARTLIDGE, NEF
    BATES, D
    FRENCH, JM
    SHAW, DA
    LANCET, 1985, 1 (8424): : 297 - 300
  • [30] Treatment of chronic constipation with colchicine: Randomized, double-blind, placebo-controlled, crossover trial
    Verne, GN
    Davis, RH
    Robinson, ME
    Gordon, JM
    Eaker, EY
    Sninksy, CA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (05): : 1112 - 1116
12345